Project Name:Rivaroxaban
Registration Classification:3+6
Formulations and specifications :Tablets: 10mg
Indications:For the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) formation after hip and knee replacement surgery.
Original Research Company:Bayer
Progress :Recently reported to the State Bureau
Category :Antithrombotic drugs